Autonomic regulation of blood pressure in premature and early menopausal women
早产和早期绝经妇女血压的自主调节
基本信息
- 批准号:10426074
- 负责人:
- 金额:$ 13.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAgeAgingAttenuatedAutomobile DrivingAutonomic DysfunctionAutonomic nervous systemBaroreflexBilateral oophorectomyBiological AgingBiology of AgingBiometryBlood PressureCardiac healthCardiovascular DiseasesCardiovascular PhysiologyCardiovascular systemCareer ChoiceCessation of lifeClinical ResearchClinical SkillsDataDoctor of PhilosophyEmpirical ResearchEstrogensFemaleFoundationsFunctional disorderFundingFutureGoalsGoldGonadal Steroid HormonesHealthHypertensionInternationalK-Series Research Career ProgramsKnowledgeLaboratoriesLinkLiteratureLong-Term EffectsMeasuresMenopauseMentored Research Scientist Development AwardMentorsMentorshipMinnesotaMissionMorbidity - disease rateMuscleNatureNerveOutcomeOutcome StudyOvarianOvaryPhysical MedicinePostmenopausePremature MenopausePremenopausePrevention strategyPreventive therapyProcessRehabilitation therapyResearchResearch ActivityRestScientistTechniquesTherapeuticTrainingTraining ActivityUnited States National Institutes of HealthUniversitiesWomanWomen&aposs Healthagedarmblood pressure regulationcardioprotectioncardiovascular disorder riskcardiovascular healthcardiovascular risk factorcareercareer developmentclinical practicedesignearly onsetexperiencehealth disparityimprovedinnovationinsightmedical schoolsmenmortalitynovel therapeutic interventionolder womenprematureprofessorprophylacticsexskill acquisitionskillsstressortechnique developmenttreatment strategy
项目摘要
Project Summary/Abstract
Aging is a risk factor for cardiovascular disease (CVD), and women who experience premature or early
menopause have a 50% greater risk for CVD-related death compared with women who experience
menopause at the typical age. Indeed, CVD increases aggressively after menopause and is the leading cause
of mortality in women in the US. Autonomic and blood pressure (BP) dysregulation, often demonstrated in
postmenopausal women, is associated with CVD. Although literature suggests that estrogen is cardioprotective
for premenopausal women, little is known regarding how the early loss of sex hormones in premature and early
menopause effect BP regulation. This application for a Mentored Research Scientist Development Award
(K01) is designed to advance knowledge important for understanding mechanisms contributing to increased
CVD in aging women and support the career of Dr. Manda L Keller-Ross, DPT, PhD, an Assistant Professor in
the Department of Rehabilitation Medicine, in the Medical School at the University of Minnesota. Dr. Keller-
Ross is the PI of the Cardiovascular Research and Rehabilitation Laboratory, where the proposed research will
take place. The long-term objectives of this proposal are to determine mechanisms that contribute to greater
risk of CVD in premature and early menopausal women. Specifically, Dr. Keller-Ross aims to determine
mechanisms driving autonomic BP regulation in premature and early menopausal women near the age of
menopausal onset (Aim 1). She will then determine mechanisms driving autonomic BP regulation in women
who have lived ≥10 years without functioning ovaries to determine the long-term effects (Aim 2). This proposal
is in line with the mission of the NIA, to understand the nature of the aging process in women and how the loss
of sex hormones contributes to the number one killer in women, CVD. Dr. Keller-Ross has a clinical research
background and seeks mentored training and skill development to enhance her knowledge on biology of aging,
women’s health specific to the cardiovascular system and menopause and advanced techniques to measure
autonomic function. She will accomplish her career development goals through a combination of formal
coursework, mentored skill and technique development for microneurography to measure muscle sympathetic
nerve activity and noninvasive measures of baroreflex function and the empirical research described above.
Dr. Keller-Ross has established an interdisciplinary mentorship team to guide her in these research and
training activities. This committee has senior-level expertise in aging research in females, autonomic regulation
of BP research and biostatistical analysis. They are eminently qualified and fully committed to assisting Dr.
Keller-Ross to further her training, research and career path and achieve her career objectives. With this
training, Dr. Keller-Ross is poised to become a leading scientist in cardiovascular health in aging women,
producing research that is directly translatable to clinical practice devising strategic preventative and
rehabilitative therapies to improve cardiovascular health, specific to aging women.
项目摘要/摘要
老龄化是心血管疾病(CVD)的危险因素,早产儿或早产儿的妇女
更年期妇女心血管疾病相关死亡的风险比经历过绝经的妇女高50%
绝经期在典型的年龄。事实上,心血管疾病在绝经后急剧增加,是主要原因。
美国女性死亡率的最高值。自主神经和血压(BP)失调,通常表现为
绝经后妇女,与心血管疾病有关。尽管文献表明雌激素对心脏有保护作用
对于绝经前妇女,关于早产儿和早产儿性激素早期丢失的原因知之甚少。
更年期影响血压调节。本申请表旨在申请导师研究科学家发展奖
(K01)旨在促进对理解有助于提高
心血管疾病在老年妇女中的作用和支持曼达·L博士的职业生涯,DPT,博士,助理教授
明尼苏达大学医学院康复医学系。凯勒医生-
罗斯是心血管研究和康复实验室的PI,拟议的研究将在那里
去做吧。这项提案的长期目标是确定有助于提高
早产和绝经早期妇女患心血管疾病的风险。具体地说,凯勒-罗斯博士的目标是确定
接近年龄的早产和绝经早期妇女自主血压调节的机制
绝经开始(目标1)。然后,她将确定驱动女性自主血压调节的机制
那些在没有卵巢功能的情况下生活了10年的≥患者,以确定其长期影响(目标2)。这项建议
是符合NIA的使命,了解女性衰老过程的本质和如何失去
性激素是女性的头号杀手,心血管疾病。凯勒-罗斯博士有一项临床研究
背景和寻求有指导的培训和技能发展,以提高她在衰老生物学方面的知识,
专门针对心血管系统和更年期的妇女健康和先进的测量技术
自主神经功能。她将通过正式的组合实现她的职业发展目标
显微神经学测量肌肉交感神经的课程、指导技能和技术发展
神经活动和非侵入性测量压力感受器反射功能和上述实验研究。
凯勒-罗斯博士已经建立了一个跨学科的指导团队来指导她的这些研究和
培训活动。该委员会在女性衰老研究、自主神经调节方面拥有高级专业知识
英国石油公司的研究和生物统计分析。他们非常有资格,并完全致力于协助Dr。
凯勒-罗斯继续推进她的培训、研究和职业道路,实现她的职业目标。有了这个
经过培训,凯勒-罗斯博士有望成为老年女性心血管健康方面的领先科学家,
生产可直接转化为临床实践的研究,制定战略预防和
康复治疗,以改善心血管健康,特别是老年妇女。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Manda Linea Keller-Ross其他文献
Manda Linea Keller-Ross的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Manda Linea Keller-Ross', 18)}}的其他基金
Vasomotor symptoms of menopause and cardiovascular disease: What is the link?
更年期的血管舒缩症状和心血管疾病:有什么联系?
- 批准号:
10739661 - 财政年份:2023
- 资助金额:
$ 13.18万 - 项目类别:
Autonomic regulation of blood pressure in premature and early menopausal women
早产和早期绝经妇女血压的自主调节
- 批准号:
9977592 - 财政年份:2020
- 资助金额:
$ 13.18万 - 项目类别:
Autonomic regulation of blood pressure in premature and early menopausal women
早产和早期绝经妇女血压的自主调节
- 批准号:
10610889 - 财政年份:2020
- 资助金额:
$ 13.18万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 13.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 13.18万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 13.18万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 13.18万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 13.18万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 13.18万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 13.18万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 13.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 13.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 13.18万 - 项目类别:
Operating Grants














{{item.name}}会员




